Modafinil does not serve as a reinforcer in cocaine abusers

Drug and Alcohol Dependence

Volumn 106, Issue 2-3, 2010, Pages 233-236

  Vosburg, Suzanne K ^a   Hart, Carl L ^a   Haney, Margaret ^a   Rubin, Eric ^a   Foltin, Richard W ^a  

^a New York State Psychiatric Institute ^*  (United States)

Author keywords

Cocaine; Human; Modafinil

Indexed keywords

COCAINE; MODAFINIL; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REINFORCEMENT;

ADULT; BENZHYDRYL COMPOUNDS; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; COCAINE; COCAINE-RELATED DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PLACEBOS; REINFORCEMENT (PSYCHOLOGY); SLEEP DISORDERS;

EID: 73549095766     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.09.002     Document Type: Article

References (30)

1. Abreu M.E., Bigelow G.E., Fleisher L., and Walsh S.L. Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology 154 (2001) 76-84
2. Balster R.L., and Bigelow G.E. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend. 70 (2003) S13-S40
3. Balster R.L., and Schuster C.R. Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J. Exp. Anal. Behav. 20 (1973) 119-129
4. Biederman J., Swanson J.M., Wigal S.B., Boellner S.W., Earl C.Q., and Lopex F.A. Modafinil ADHD Study Group. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J. Clin. Psychiatry 67 (2006) 727-735
5. Blackhall L., Petroni G., Shu J., Baum L., and Farace E. A pilot study evaluating the safety and efficacy of modafinil for cancer-related fatigue. J. Palliat. Med. 12 (2009) 433-439
6. Comer S.D., Sullivan M.A., Whittington R.A., Vosburg S.K., and Kowalczyk W.J. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 33 (2008) 1179-1191
7. Dackis C., and O'Brien C. Glutamatergic agents for cocaine dependence. Ann. N. Y. Acad. Sci. 1003 (2003) 328-345
8. Dackis C.A., Lynch K.G., Yu E., Samaha F.F., Kampman K.M., Cornish J.W., Rowan A., Poole S., White L., and O'Brien C.P. Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend. 70 (2003) 29-37
9. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., and O'Brien C.P. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30 (2005) 205-211
10. Deroche-Gamonet V., Darnaudéry M., Bruins-Slot L., Piat F., Le Moal M., and Piazza P.V. Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology 161 (2002) 387-395
11. Foltin R.W., and Fischman M.W. Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J. Pharmacol. Exp. Ther. 261 (1992) 841-849
12. Foltin R.W., Ward A.S., Haney M.H., Hart C.L., and Collins E.D. The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend. 70 (2003) 149-157
13. Gold L.H., and Balster R.L. Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology 126 (1996) 286-292
14. Hart C.L., Haney M., Vosburg S.K., Rubin E., and Foltin R.W. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33 (2008) 761-768
15. Jasinski D.R. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J. Psychopharmacol. 14 (2000) 53-60
16. Jasinski D.R., and Kovačević-Ristanović R. Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin. Neuropharmacol. 23 (2000) 149-156
17. Karila L., Gorelick D., Weinstein A., Noble F., Benyamina A., Coscas S., Blecha L., Lowenstein W., Martinot J.L., Reynaud M., and Lépine J.P. New treatments for cocaine dependence: a focused review. Int. J. Neuropsychopharmacol. 11 (2008) 425-438
18. Lam J.Y., Freeman M.K., and Cates M.E. Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Ann. Pharmacother. 41 (2007) 1005-1012
19. Lange R., Volkmer M., Heesen C., and Liepert J. Modafinil effects in multiple sclerosis patients with fatigue. J. Neurol. 256 (2009) 645-650
20. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., Johnson R., Livni E., Spencer T.J., Bonab A.A., Miller G.M., and Fischman A.J. Modafinil occupies dopamine and norepinephrine transporteds in vivo and modulates the transporters and trace amine activity in vitro. J. Pharmacol. Exp. Ther. 319 (2006) 561-569
21. Malcolm R., Book S.W., Moak D., DeVane L., and Czepowicz V. Clinical applications of modafinil in stimulant abusers: low abuse potential. Am. J. Addict. 11 (2002) 247-249
22. Malcolm R., Swayngim K., Donovon J.K., DeVane C.L., Elkashefl A., Chiang N., Khan R., Mojsiak J., Myrick D.L., Hedden S., Cochran K., and Woolson R.F. Modafinil and cocaine interactions. Am. J. Drug Alcohol Abuse 32 (2006) 577-587
23. Myrick H., Malcolm R., Taylor B., and LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance-a review of abuse liability issues. Ann. Clin. Psychiatry 16 (2004) 101-109
24. Pataki C.S., Feinberg D.T., and McGough J.J. New drugs for the treatment of attention-deficit/hyperactivity disorder. Expert Opin. Emerg. Drugs 9 (2004) 293-302
25. Rush C.R., Kelly T.H., Hays L.R., Baker R.W., and Wooten A.F. Acute behavioral and physiological effects of modafinil in drug abusers. Behav. Pharmacol. 13 (2002) 105-115
26. Rush C.R., Kelly T.H., Hays L.R., and Wooten A.F. Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend. 67 (2002) 311-322
27. Samaha A.N., Mallet N., Ferguson S.M., Gonon F., and Robinson T.E. The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. J. Neurosci. 24 (2004) 6362-6370
28. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., Wang G.J., Jayne M., Hooker J.M., Wong C., Hubbard B., Carter P., Warner D., King P., Shea C., Xu Y., and Miench L. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301 (2009) 1148-1154
29. Volkow N.D., Fowler J.S., Wang G.J., Baler R., and Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 (2009) 3-8
30. Zolkowska D., Jain R., Rothman R.B., Partilla J.S., Roth B.L., Setola V., Prisinzano T.E., and Baumann M.H. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J. Pharmacol. Exp. Ther. 329 (2009) 738-746